0001203311-15-000042.txt : 20150825 0001203311-15-000042.hdr.sgml : 20150825 20150825203008 ACCESSION NUMBER: 0001203311-15-000042 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150820 FILED AS OF DATE: 20150825 DATE AS OF CHANGE: 20150825 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HIMES VAUGHN B CENTRAL INDEX KEY: 0001361966 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 151074509 MAIL ADDRESS: STREET 1: C/O SEATTLE GENETICS, INC. STREET 2: 21823 30TH DRIVE SE CITY: BOTHELL STATE: WA ZIP: 98021 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2015-08-20 0 0001060736 SEATTLE GENETICS INC /WA SGEN 0001361966 HIMES VAUGHN B 21823 30TH DRIVE SE BOTHELL WA 98021 0 1 0 0 EVP, Proc Svcs & Tech Ops Common Stock 2015-08-20 4 S 0 5997.0 42.0245 D 61212 D Common Stock 2015-08-25 4 A 0 15000.0 0.0 A 76212 D Incentive Stock Option (right to buy) 39.15 2015-08-25 4 A 0 2554.0 0.0 A 2025-08-25 Common Stock 2554 2554 D Non-Qualified Stock Option (right to buy) 39.15 2015-08-25 4 A 0 34946.0 0.0 A 2025-08-25 Common Stock 34946 34946 D Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. These shares represent restricted stock units and will be settled in common stock upon vesting. Restricted stock units shall vest in full three (3) years from grant date. Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Shares shall vest at a rate of 25% one year from grant date and monthly thereafter until all shares are fully vested four years from grant date. Vaughn B. Himes 2015-08-25